Clinical Trials Browser

Anorexia, Hematologic Neoplasms

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck

Opioid-Related Disorders

Nausea, Vomiting

Glioblastoma, Gliosarcoma

Nausea, Neoplasms, Vomiting

Breast Neoplasms

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Neoplasms, Vomiting

Gynecologic Cancer

Nausea, Vomiting, Hematologic Neoplasms

Multiple Myeloma, Nausea

Nausea, Vomiting, Neoplasms, Plasma Cell

Anorexia Nervosa with Significantly Low Body Weight

Carcinoma, Non-Small-Cell Lung

Anorexia, Cachexia

Neoplasms, Nutrition Disorders, Prosthesis Failure

Hematologic Neoplasms

Advanced Cancer

Nausea, Testicular Neoplasms, Vomiting

Breast Neoplasms, Nausea

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Nausea, Vomiting, Postoperative Nausea and Vomiting

Nausea, Vomiting

Lung Neoplasms, Vomiting

Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy

Breast Neoplasms

Neoplasms, Germ Cell and Embryonal

Nausea, Vomiting

Hematologic Neoplasms

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

Stomach Neoplasms

Cachexia, Weight Loss

Nausea, Vomiting

Pain, Hematologic Neoplasms

Nausea, Neoplasms

Clinical Trials

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

POINT

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

FONDO-LOW

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Olanzapine Anorexia Cachexia

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

Olanzapine for Cancer Related Anorexia-cachexia Syndrome

Nutrition Impact on Immunotherapy of Cancer

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer

OLNEPA

OLN-EME

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

OFFER

Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study

Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care

FOND-O

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy

Olanzapine in Patients With Advanced Cancer and Weight Loss

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer